Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 10.995
Filtrar
1.
Homeopathy ; 112(1): 1-2, 2023 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-36691386

Assuntos
Homeopatia
2.
BMC Complement Med Ther ; 22(1): 338, 2022 Dec 22.
Artigo em Inglês | MEDLINE | ID: mdl-36550537

RESUMO

BACKGROUND: Patients with seasonal allergic rhinitis (SAR) frequently use homeopathic therapy. Although there is some evidence that homeopathy may be effective in treating symptoms of SAR, there is a lack of high-quality clinical trials. Therefore, the aim of the homeopathy for SAR (HOMEOSAR) trial is to determine the efficacy of individualized or standardized homeopathic drug treatment compared to placebo regarding rhinitis-related quality of life in patients with SAR. METHODS: This randomized, placebo-controlled, double-blind, three-armed intervention study will be conducted at two university hospital outpatient clinics for complementary and integrative medicine in Berlin and in 12 office-based practices specializing in homeopathic treatment in Germany. A total of 270 patients with clinical symptoms of SAR and positive allergy test to birch and grass pollen will receive homeopathic anamnesis and subsequently be randomized into (a) standardized homeopathic drug treatment with Galphimia Glauca (potency D6), (b) individualized homeopathic drug treatment (D6), or (c) placebo. All three groups can receive on-demand rescue medication as needed. Treatment will consist of two consultations and daily intake of the study medication for 4 weeks during the pollen season. The primary outcome is the mean overall score of the Rhinitis Quality of Life Questionnaire (RQLQ) in weeks 3 and 4, analyzed using analysis of covariance (adjusted for baseline RQLQ overall score and study center). A closed testing procedure will be used to control the overall type I error comparing the 3 treatment groups. Secondary outcomes include the overall RQLQ and its seven domain scores, responder status (decrease in RQLQ overall score of at least 0.5 points compared to the baseline value), use of rescue medication, intensity of total and individual SAR symptoms based on visual analog scale, generic health-related quality of life, safety, utilization of health care resources and associated costs. In addition, a qualitative data analysis is planned. CONCLUSION: The results of our study will contribute to clarifying the possible therapeutic effects of homeopathic drug treatment for patients with SAR. TRIAL REGISTRATION: This study has been registered in the German Clinical Trial Registry with trial ID DRKS00018081 on June 09, 2020.


Assuntos
Homeopatia , Rinite Alérgica Sazonal , Rinite , Humanos , Rinite Alérgica Sazonal/tratamento farmacológico , Rinite Alérgica Sazonal/diagnóstico , Qualidade de Vida , Método Duplo-Cego
3.
Cochrane Database Syst Rev ; 12: CD005974, 2022 12 13.
Artigo em Inglês | MEDLINE | ID: mdl-36511520

RESUMO

BACKGROUND: Acute respiratory tract infections (ARTIs) are common and may lead to complications. Most children experience between three and six ARTIs annually. Although most infections are self-limiting, symptoms can be distressing. Many treatments are used to control symptoms and shorten illness duration. Most treatments have minimal benefit and may lead to adverse events. Oral homeopathic medicinal products could play a role in childhood ARTI management if evidence for their effectiveness is established. This is an update of a review first published in 2018. OBJECTIVES: To assess the effectiveness and safety of oral homeopathic medicinal products compared with placebo or conventional therapy to prevent and treat ARTIs in children. SEARCH METHODS: We searched CENTRAL (2022, Issue 3), including the Cochrane Acute Respiratory Infections Specialised Register, MEDLINE (1946 to 16 March 2022), Embase (2010 to 16 March 2022), CINAHL (1981 to 16 March 2022), AMED (1985 to 16 March 2022), CAMbase (searched 16 March 2022), and British Homeopathic Library (searched 26 June 2013 - no longer operating). We also searched the WHO ICTRP and ClinicalTrials.gov (16 March 2022), checked references, and contacted study authors to identify additional studies. SELECTION CRITERIA: We included double-blind randomised controlled trials (RCTs) or double-blind cluster-RCTs comparing oral homeopathy medicinal products with identical placebo or self-selected conventional treatments to prevent or treat ARTIs in children aged 0 to 16 years. DATA COLLECTION AND ANALYSIS: We used standard methodological procedures expected by Cochrane. MAIN RESULTS: In this 2022 update, we identified three new RCTs involving 251 children, for a total of 11 included RCTs with 1813 children receiving oral homeopathic medicinal products or a control treatment (placebo or conventional treatment) for ARTIs. All studies focused on upper respiratory tract infections (URTIs), with only one study including some lower respiratory tract infections (LRTIs). Six treatment studies examined the effect on URTI recovery, and five studies investigated the effect on preventing URTIs after one to four months of treatment. Two treatment and three prevention studies involved homeopaths individualising treatment. The other studies used predetermined, non-individualised treatments. All studies involved highly diluted homeopathic medicinal products, with dilutions ranging from 1 x 10-4 to 1 x 10-200. We identified several limitations to the included studies, in particular methodological inconsistencies and high attrition rates, failure to conduct intention-to-treat analysis, selective reporting, and apparent protocol deviations. We assessed three studies as at high risk of bias in at least one domain, and many studies had additional domains with unclear risk of bias. Four studies received funding from homeopathy manufacturers; one study support from a non-government organisation; two studies government support; one study was co-sponsored by a university; and three studies did not report funding support. Methodological inconsistencies and significant clinical and statistical heterogeneity precluded robust quantitative meta-analysis. Only four outcomes were common to more than one study and could be combined for analysis. Odds ratios (OR) were generally small with wide confidence intervals (CI), and the contributing studies found conflicting effects, so there was little certainty that the efficacy of the intervention could be ascertained. All studies assessed as at low risk of bias showed no benefit from oral homeopathic medicinal products, whilst trials at unclear or high risk of bias reported beneficial effects. For the comparison of individualised homeopathy versus placebo or usual care for the prevention of ARTIs, two trials reported on disease severity; due to heterogeneity the data were not combined, but neither study demonstrated a clinically significant difference. We combined data from two trials for the outcome need for antibiotics (OR 0.79, 95% CI 0.35 to 1.76; low-certainty evidence). For the comparison of non-individualised homeopathy versus placebo or usual care for the prevention of ARTIs, only the outcome recurrence of ARTI was reported by more than one trial; data from three studies were combined for this outcome (OR 0.60, 95% CI 0.21 to 1.72; low-certainty evidence). For the comparison of both individualised and non-individualised homeopathy versus placebo or usual care for the treatment of ARTIs, two studies provided data on short-term cure (OR 1.31, 95% CI 0.09 to 19.54) and long-term cure (OR 1.01, 95% CI 0.10 to 9.96; very low-certainty evidence). The studies demonstrated an opposite direction of effect for both outcomes. Six studies reported on disease severity but were not combined as they used different scoring systems and scales. Three studies reported adverse events (OR 0.79, 95% CI 0.16 to 4.03; low-certainty evidence). AUTHORS' CONCLUSIONS: Pooling of five prevention and six treatment studies did not show any consistent benefit of homeopathic medicinal products compared to placebo on ARTI recurrence or cure rates in children. We assessed the certainty of the evidence as low to very low for the majority of outcomes. We found no evidence to support the efficacy of homeopathic medicinal products for ARTIs in children. Adverse events were poorly reported, and we could not draw conclusions regarding safety.


Assuntos
Homeopatia , Infecções Respiratórias , Criança , Humanos , Antibacterianos/uso terapêutico , Homeopatia/efeitos adversos , Análise de Intenção de Tratamento , Ensaios Clínicos Controlados Aleatórios como Assunto , Infecções Respiratórias/prevenção & controle , Infecções Respiratórias/tratamento farmacológico
4.
Multimedia | Recursos Multimídia | ID: multimedia-10012

RESUMO

Um bate papo com Dr. Carlos Brunini que vai nos contar sobre sua trajetória de mais de 40 anos de prática médica homeopática.


Assuntos
Homeopatia/história , Pessoas Famosas , Médicos Homeopatas
5.
Homeopathy ; 111(4): 233-234, 2022 11.
Artigo em Inglês | MEDLINE | ID: mdl-36379229
7.
Vet Q ; 42(1): 192-198, 2022 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-36316960

RESUMO

Background: There is an increased interest in Non-Conventional Therapies (NCTs), often referred to as complementary and alternative medicines, in veterinary clinical practice.Aim: To map the bibliometric outputs of NCTs in veterinary medicine, and identify which are most prevalent, and the extent to which their publishing has increased.Methods: Text mining algorithms were applied to detect 17 NCTs-related terms (acupuncture, ayurveda/ayurvedic, traditional Chinese medicine, traditional medicine, chiropractic, electroacupuncture, essential oil, plant extract, ethnopharmacology, herbal medicine, homeopathy, low-level laser therapy, medicinal plant, natural product, osteopathy, phytotherapy, and massage) in the title, abstract or keywords of all retrievable literature until 2020 under the PubMed MeSH term 'veterinary' (N = 377 556). Point prevalence, incidence by decade and cumulative incidence were calculated.Results: Bibliometric trend analysis revealed an overall increase in NCTs-related terms over the last 20 years, with a substantial growth of studies mentioning plant extracts, essential oils and medicinal plants. Traditional Chinese medicine, herbal medicine and natural product have also increased in the same period, although their numbers remain low. Conversely, reference to acupuncture has decreased in the last decade when compared with the previous decade, whereas references to homeopathy, electroacupuncture, osteopathy and chiropractic remained scarce, suggesting that their use in veterinary clinical practice may not be based on published evidence.Conclusion: Further reviews to explore this issue are warranted, differentiating secondary from primary literature, and assessing relevance and methodological quality of individual studies, following the principles of evidence-based veterinary medicine.


Assuntos
Produtos Biológicos , Terapias Complementares , Homeopatia , Animais , Terapias Complementares/veterinária , Fitoterapia/veterinária , Homeopatia/veterinária , Bibliometria
8.
Multimedia | Recursos Multimídia | ID: multimedia-10008

RESUMO

A live programada terá como objetivos apresentar as mudanças e atualizações no portal da BVS Homeopatia e o novo sistema da Biblioteca da APH (gnuteca) visando a integração de bibliotecas de outras federadas e o fortalecimento, divulgação e representação do conhecimento nacional de informação em homeopatia no Brasil. Também será apresentado o projeto de construção dessa rede de contribuição integrada de bibliotecas junto com as Federadas


Assuntos
Homeopatia/história , Bibliotecas Digitais/história , Divulgação da Homeopatia , Disseminação de Informação
9.
Multimedia | Recursos Multimídia | ID: multimedia-9968

RESUMO

O que as zonas azuis Okinawa (Japão), Sardenha (Itália), Nicoya (Costa Rica), Icaria (Grécia) e Loma Linda (Califórnia, EUA) tem em comum? O que faz com que elas tenham uma maior concentração de pessoas centenárias do que o restante do planeta? Dr. Samuel Hahnemann publicou um manual “O amigo da Saúde” que lhe trouxe sucesso, neste manual de dois volumes, Hahnemann enunciou as regras a seguir para manter uma boa saúde. De Hahnemann com suas pesquisas em Homeopatia e doenças crônicas aos dias atuais com as evidências da medicina do estilo de vida pala longevidade saudável e promoção de saúde, você esta convidado para esta live imperdível com Dr. Lucas Pacheco.


Assuntos
Homeopatia , Longevidade , Qualidade de Vida , Promoção da Saúde , Estilo de Vida Saudável
10.
Altern Ther Health Med ; 28(7): 72-79, 2022 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-36074959

RESUMO

Background and Objective: Homoeopathy has played a notable role in managing epidemics in the past. The Ministry of Ayush, Government of India, declared Arsenicum album 30 C as a prophylactic for Covid-19, which was followed by the distribution of the medicine across India. The Central Council for Research in Homoeopathy (CCRH) collected post-prophylactic consumption data of individuals from various colleges over months, which created a data pool. Considering the importance of these mass-level data and their possible impact on public healthcare decisions, the information gathered from this heterogeneous population cohort was subjected to a retrospective data analysis to observe the incidence of Covid-19 in the community. Methods: Data from 50 colleges from February-August 2020 showed that 10.6 million people in 13 states of India received prophylactic medicine during the study period. The data was collected from individuals three weeks following prophylactic consumption for a retrospective analysis. The incidence of Covid-19 was assessed. Results: The data of 584 980 individuals who met the study criteria were included in the analysis. The incidence of Covid-19 in the population cohort was 13.58 per 10 000-person weeks (95% CI, 13.04 to 14.14), which remained near-constant over time despite the increasing disease burden in the country (12.87 to 14.52 per 10 000-person weeks). Consumption of the prophylactic significantly reduced the risk of contracting Covid-19 in high-risk groups as compared to their counterparts. Conclusion: The study concludes that Arsenicum album 30 C has a potential prophylactic effect against Covid-19. Further controlled studies are recommended to establish a causal relation.


Assuntos
Arsenicais , COVID-19 , Homeopatia , Materia Medica , COVID-19/epidemiologia , Humanos , Estudos Retrospectivos
11.
Cad Saude Publica ; 38(9): e00261821, 2022.
Artigo em Inglês | MEDLINE | ID: mdl-36169510

RESUMO

Despite the controversy about its efficacy, homeopathy is considered a medical practice alternative to the conventional medical model. Prevalence of homeopathy use varies greatly among countries and the literature has conflicting evidence about the relation between sociodemographic factors and health conditions associated with homeopathy use. We aim to estimate the prevalence of homeopathy use and its association with self-perceived health status, depression, and sociodemographic factors. We used data from 90,846 participants in the 2019 Brazilian National Survey of Health (PNS 2019), a population-based study with complex and probabilistic sampling. Sociodemographic and clinical data and information on homeopathy use during the last 12 months were collected. The Patient Health Questionnaire-9 (PHQ-9) was used to assess depression. All variables were categorized. Logistic regression models were built to obtain crude and adjusted odds ratios (OR) and 95% confidence intervals (95%CI). The prevalence of homeopathy use was 0.99% (95%CI: 0.98-1.00). In the adjusted analysis, the following variables were associated with higher use of homeopathy: female gender, age above 51 years, white ethnicity, higher socioeconomic and educational attainment, residence in Southern/Southeastern Brazil, poorer self-reported health status, and depression. Brazil shows increased offer of complementary medicine, including homeopathy. Nevertheless, the use of homeopathy treatment is very low and clearly associated with a higher socioeconomic status, poorer self-reported health status, and depression.


Assuntos
Terapias Complementares , Homeopatia , Brasil/epidemiologia , Escolaridade , Feminino , Humanos , Pessoa de Meia-Idade , Prevalência
12.
Rev. Hosp. Ital. B. Aires (2004) ; 42(3): 135-138, sept. 2022. ilus, tab
Artigo em Espanhol | LILACS, BINACIS, UNISALUD | ID: biblio-1396307

RESUMO

Árnica es una planta medicinal de la especie Arnica montana, endémica en Europa Central y Meridional, perteneciente a la familia Asteracae; rica en flavonoides y compuestos fenólicos, lactonas, helenalina y ácido hexurónico que le dan propiedades cicatrizantes, antiinflamatorias, analgésicas, antimicrobianas y anticoagulantes. Se utiliza en casos de contusiones, dolores musculares, reumáticos y hematomas profundos. El artículo describe ocho casos, que presentaron hematoma profundo por punción infructuosa, en pacientes con insuficiencia renal crónica terminal con esquema de hemodiálisis, donde se aplicó árnica en gel. Por medio de fotografías se registró cómo los hematomas revirtieron a partir del tercer día, mientras que el dolor disminuyó en un 50% al tercer día. (AU)


Arnica is a medicinal plant of the species Arnica Montana, endemic in Central and Southern Europe, it belongs to the Asteracae family, rich in flavonoids and phenolic compounds, lactones, helenalin and hexuronic acid that give it healing, anti-inflammatory, analgesic, antimicrobial and anticoagulant properties. It is used in cases of bruises, muscle pain, rheumatic pain and deep bruises. The article describes eight patients with terminal chronic renal failure under hemodialysis, who presented deep hematoma due to unsuccessful puncture of their dialysis fistula. All patients were treated with local gel arnica. Verbal analogue scale (VAS) and qualitative visual image analysis (photography) on how the hematomas reverted on the third day was analyzed. (AU)


Assuntos
Humanos , Masculino , Feminino , Adulto , Pessoa de Meia-Idade , Idoso , Idoso de 80 Anos ou mais , Adulto Jovem , Arnica , Manejo da Dor/métodos , Hematoma/terapia , Homeopatia , Medição da Dor , Punções/efeitos adversos , Diálise Renal , Falência Renal Crônica/complicações
13.
Multimedia | Recursos Multimídia | ID: multimedia-9914

RESUMO

Trata-se de um tema que apresenta paralelos com a Homeopatia, uma vez que é voltado à totalidade do organismo. Na atualidade muitos estudos são voltados a esse novo paradigma. Aborda-se a resistência oferecida pelo modelo mecanicista/fragmentado da medicina dominante.


Assuntos
Homeopatia , Sistemas Neurossecretores/imunologia , Processo Saúde-Doença , Organon , Filosofia
14.
Multimedia | Recursos Multimídia | ID: multimedia-9879

RESUMO


Assuntos
Homeopatia , Promoção da Saúde
15.
Multimedia | Recursos Multimídia | ID: multimedia-9880

RESUMO


Assuntos
Homeopatia , Promoção da Saúde
16.
Multimedia | Recursos Multimídia | ID: multimedia-9881

RESUMO


Assuntos
Homeopatia , Promoção da Saúde
17.
Multimedia | Recursos Multimídia | ID: multimedia-9883

RESUMO

Neste dia 30 de abril de 2020 celebramos os 91 anos de vida da Profa. Dra. Anna Kossak Romanach, médica dermatologista e homeopata. Hoje residente em Curitiba, a Dra Anna abriu as portas da sua casa para nos contar um pouco da sua trajetória na Homeopatia. Cercada de livros e de história, ela ainda mostra entusiasmo em ensinar as novas gerações de médicos homeopatas. Dra Anna abre uma série de vídeos que a Associação Médica Homeopática Brasileira fará intitulados “Personalidades da Homeopatia”, que é uma justa homenagem aos profissionais para que continuem trabalhando pelo fortalecimento da Homeopatia brasileira. Obrigado Dra Anna por seus ensinamentos e por sua luta!


Assuntos
Homeopatia/história , Pessoas Famosas
18.
Multimedia | Recursos Multimídia | ID: multimedia-9885

RESUMO

A APH mais uma vez tem a honra de apresentar aos médicos homeopatas brasileiros, um renomado e conceituado homeopata contemporâneo e palestrante internacional, o Didier Grandgeorge. Tema Homeopatia nas Fases da Vida O tema “Homeopatia nas Fases da Vida” é o resultado de observações clínicas de uma vida inteira de intensa prática junto aos seus pacientes. Mostrando um profundo e íntimo conhecimento de remédios, Grandgeorge nos convida a olhar para esses medicamentos e suas ações de uma perspectiva diferente, de forma a explicar cada uma das sucessivas fases da vida, referenciando sintomas físicos e psicológicos comuns e seus remédios homeopáticos com sua utilização, sua clínica e sua simbologia.


Assuntos
Homeopatia , Congresso
19.
Multimedia | Recursos Multimídia | ID: multimedia-9886

RESUMO

Senadores promovem sessão especial para comemorar o Dia Internacional da Homeopatia (10 de abril). A data é alusiva ao aniversário de Samuel Hahnemann, médico alemão fundador da homeopatia, prática que chegou no Brasil em 1840. O requerimento para a sessão foi apresentado pelo senador Nelsinho Trad (PSD-MS).


Assuntos
Homeopatia , Promoção da Saúde
20.
Homeopathy ; 111(4): 252-260, 2022 11.
Artigo em Inglês | MEDLINE | ID: mdl-35917822

RESUMO

BACKGROUND: Asymptomatic COVID-19 subjects can transmit the infection for as many as 14 days and are regarded as a significant factor in the rapid spread of the COVID-19 pandemic. This exploratory study aimed to determine any additional benefits of selected homeopathic medicines compared with placebo in asymptomatic COVID-19 individuals receiving standard care. METHODS: This open-label, randomized, placebo-controlled, exploratory trial was undertaken at a COVID Care Centre (CCC) in Madhya Pradesh, India. Patients (n = 200, 18-65 years, both sexes) having a positive RT-PCR and asymptomatic during admission were enrolled. They were randomly assigned to one of four groups (each n = 50): Arsenicum album 30C (Ars. alb.), Camphora 1M (Camph.), Bryonia alba 30C (Bry. alb.) and placebo (Pl.). All the patients were given standard care. The primary outcome was the number of patients becoming RT-PCR negative for SARS-CoV-2 at days 5, 10 and 15. RESULTS: In total, 200 asymptomatic COVID-19 patients were enrolled. One hundred and seventy-seven patients became RT-PCR negative by day 15; 88%, 80%, 98% and 88% from Ars. alb., Camph., Bry. alb. and Pl. respectively. A Chi-square test of association for the total patients who became RT-PCR negative for SARS-Cov-2 in each group showed a marginal statistical significance (Chi-square: 8.1, p = 0.04). A two-proportion Z-test comparing each pre-identified homeopathic medicine with placebo showed marginal statistical significance (p = 0.05) for Bry alb. only. Median time in days to RT-PCR negative (Kaplan Meier analysis) was 10 days in each of the groups. CONCLUSION: There was some evidence that, compared with Ars alb., Camph. or Pl., Bry. alb. was associated with an increased number of patients who became RT-PCR negative for COVID-19 by day 15. The possible effect exerted needs to be investigated in additional research.


Assuntos
Homeopatia , Materia Medica , Humanos , Masculino , Feminino , Pandemias , SARS-CoV-2 , Pesquisa , Materia Medica/uso terapêutico , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...